How to Cite
Abstract
To study the role of retroperitoneal lymphadenectomy in epithelial ovarian cancer (OC) the work was divided into two parts. In the first part for a retrospective analysis 852 patients with stage I-IV OC, who were treated from January 2000 to January 2014, were selected to investigate the localization of the first relapse of the disease. In the second part, prospective from August 2016 to April 2017, in 28 patients with stage I-IV OC the surgical stage of the combined treatment was supplemented by iliac-pelvic and para-aortic lymphadenectomy; in this group the results of surgical staging were studied. The incidence of isolated recurrence in para-aortic lymph nodes in the group of early OC was 3/28 (11%), in pelvic 2/28 (7%), whereas in the group of advanced OC - in para-aortic lymph nodes 9/24 (37%), in iliac-pelvic 10/24 (42%), combined in pelvic and para-aortic lymph nodes 5/24 (21%). In the prospective group the lesion of pelvic and para-aortic lymph nodes was observed in 2/28 (7%) of patients with the presumed I stage of the disease and in 2/28 (7%) with the presumed stage II, which resulted in re-staging of the disease. In 2 cases the clinical IA and IB stages were re-staged to IIIA and this required 6 courses of chemotherapy. In 2/28 (7%) patients metastases to para-aortic lymph nodes were detected in the absence of pelvic lesions.References
Юркова Л.Е. Лимфогенное метастазирование злокачественных опухолей яичников // Вопросы онкологии. - 1981. - № 8. - С. 48-52.
Юркова Л.Е., Винокуров В.Л. Клиническая диагностика лимфогенных метастазов рака яичников // Вопросы онкологии. - 1984. - № 3. - С. 87-93.
Ayhan A., Gultekin M., Taskirana C. et al. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables // Gynecol. Oncol. - 2005. - Vol. 95. - P. 400-404.
Burghardt E., Girardi F., Lahousen M. et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer // Gynecol. Oncol. - 1991. - Vol. 40. - P. 103-106.
Benedetti Panici P.L., Maggioni A., Hacker N. et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial // J. Natl. Cancer Inst. - 2005. - Vol. 97. - P. 560-566.
Berek J.S., Bertelsen K., du Bois A. et al. Advanced epithelial ovarian cancer: 1998 consensus statements // Ann. Oncol. - 1999. - Vol. 10. - № 1. - P. 8792.
Cass I., Li A.J., Runowicz C.D., Fields A.L. et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas // Gynecol. Oncol. - 2001. - Vol. 80. - P. 56-61.
Desteli G.A., Gultekin M., Usubutun A., Yuce K., Ayhan A. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature // World J. Surg. Oncol. - 2010. - Vol. 30 (8). - P. 106. - DOI: 10.1186/1477-7819-8-106
Fournier M., Stoeckle E., Guyon F., Brouste V. et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients // Int. J. Gynecol. Cancer. - 2009. - Vol. 19. - P. 1307-1313.
Friedlander M., Trimble E., Tinker A. et al. Clinical Trials in Recurrent Ovarian Cancer // Int. J. Gynecol. Cancer. - 2011. - Vol. 21. - Р. 771-775.
Gore M.E., Atkinson R.J., Thomas H. et al. A phase II trial of ZD0473 in platinum-pretreated ovarian cancer // Eur. J. Cancer. - 2002. - Vol. 18. - Р. 2416-2420.
Harter P. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer // Int. J. Gynecol. Cancer. - 2007. - Vol. 17. - P. 1238-1244.
Kleppe M., Kraima A.C., Kruitwagen R.F. et al. Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer // Int. J. Gynecol. Cancer. - 2015. - Vol. 25 (8). - P. 14051414.
Kimmig R., Peter Rusch, Paul Buderath, Bahriye Aktas. Aortic utero-ovarian sentinel nodes and left infrarenal aortic lymph node dissection by ICG supported navigation // J. Gynecol. Oncol. -2017. - Vol. 28(3). - P. 41.
Morice P. Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications // J. Am. Coll. Surg. - 2003. - Vol. 197. - P. 198-205.
Negishi H., Takeda M., Fujimoto T. et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer // Gynecol. Oncol. - 2004. - Vol. 94. - P. 161-166.
Onda T., Yoshikawa H., Yokota H. et al. Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy // Cancer. - 1996. - Vol. 78. - P. 803-808.
Sakuragi N., Yamada H., Oikawa M. et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0) // Gynecol. Oncol. - 2000. - Vol. 79. - P. 251-255.
Suzuki M., Ohwada M., Yamada T. et al. Lymph node metastasis in stage I epithelial ovarian cancer // Gynecol. Oncol. - 2000. - Vol. 79. - P. 305-308.
Takeshima N., Hirai Y., Umayahara K. et al. Lymph Node Metastasis in Ovarian Cancer: Difference Between Serous and Non-Serous Primary Tumors // Gynecol. Oncol. - 2005. - Vol. 99. - P. 427-431.
Tsumura N., Sakuragi N., Hareyama H. et al. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma // Int. J. Cancer. - 1998 - Vol. 79. - P. 526-530.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018